8-K: Aflac Reports Solid Q1 2025 Adjusted Earnings, Driven by Strong Persistency and Sales Growth in Japan

Aflac Incorporated announced its first quarter 2025 results, highlighting solid adjusted earnings despite a decrease in net earnings due to net investment losses, and declared a second quarter dividend of $0.58 per share.

Summary

• Aflac Incorporated reported total revenues of $3.4 billion for Q1 2025, a decrease from $5.4 billion in Q1 2024, primarily due to net investment losses.
• Net earnings were $29 million, or $0.05 per diluted share, compared to $1.9 billion, or $3.25 per diluted share in the previous year.
• Adjusted earnings were $906 million, a 5.7% decrease from $961 million in Q1 2024, while adjusted earnings per diluted share remained flat at $1.66.
• Shareholders equity increased to $26.3 billion, or $48.55 per share, at March 31, 2025, compared to $23.5 billion, or $41.27 per share, at March 31, 2024.
• Aflac Japan's net earned premiums decreased by 5.0% in yen terms and 7.4% in dollar terms.
• Aflac Japan's total new annualized premium sales increased by 12.6% to $93 million.
• Aflac U.S. net earned premiums increased by 1.8% to $1.5 billion.
• Aflac U.S. sales increased by 3.5% to $309 million.
• The board of directors declared a second quarter dividend of $0.58 per share, payable on June 2, 2025.
• Aflac repurchased $900 million of its common shares in Q1 2025.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While adjusted earnings were solid and there were positives in sales and persistency, the significant decrease in net earnings due to investment losses tempers the overall outlook.

Positives

• Aflac Japan's new annualized premium sales increased 12.6% to $93 million, driven by strong sales of Tsumitasu and Miraito.
• Aflac U.S. net earned premiums increased 1.8% to $1.5 billion, reflecting improved sales and persistency.
• Aflac U.S. sales increased 3.5% to $309 million, driven by sales of group products.
• Shareholders equity increased to $26.3 billion, or $48.55 per share.
• The company repurchased $900 million in shares during the quarter, indicating a commitment to returning capital to shareholders.
• Aflac's capital position remains strong, with an SMR above 950% and an estimated regulatory ESR above 250%.

Negatives

• Total revenues decreased to $3.4 billion from $5.4 billion due to net investment losses of $963 million compared to net investment gains of $951 million in the prior year.
• Net earnings decreased significantly to $29 million, or $0.05 per diluted share, from $1.9 billion, or $3.25 per diluted share.
• Adjusted earnings decreased by 5.7% to $906 million.
• Aflac Japan's net earned premiums decreased by 5.0% in yen terms and 7.4% in dollar terms, mainly due to internal cancer reinsurance transactions and limited-pay policies reaching paid-up status.
• Adjusted net investment income in Aflac Japan decreased 7.6% to 89.2 billion yen primarily due to lower floating rate income.
• The annualized return on average shareholders equity in the first quarter was 0.4%.

Risks

• Difficult conditions in global capital markets and the economy, including inflation.
• Defaults and credit downgrades of investments.
• Global fluctuations in interest rates and exposure to significant interest rate risk.
• Concentration of business in Japan.
• Limited availability of acceptable yen-denominated investments.
• Foreign currency fluctuations in the yen/dollar exchange rate.
• Differing interpretations applied to investment valuations.
• Significant valuation judgments in determination of expected credit losses recorded on the Company's investments.
• Decreases in the Company's financial strength or debt ratings.
• Decline in creditworthiness of other financial institutions.
• The Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners.
• Deviations in actual experience from pricing and reserving assumptions.
• Ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives.
• Interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality, integrity or privacy of sensitive data residing on such systems.
• Subsidiaries' ability to pay dividends to the Parent Company.
• Inherent limitations to risk management policies and procedures.
• Operational risks of third-party vendors.
• Tax rates applicable to the Company may change.
• Failure to comply with restrictions on policyholder privacy and information security.
• Extensive regulation and changes in law or regulation by governmental authorities.
• Competitive environment and ability to anticipate and respond to market trends.
• Catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, major public health issues, terrorism or other acts of violence, and damage incidental to such events.
• Ability to protect the Aflac brand and the Company's reputation.
• Ability to effectively manage key executive succession.
• Changes in accounting standards.
• Level and outcome of litigation or regulatory inquiries.
• Allegations or determinations of worker misclassification in the United States.

Future Outlook

Aflac intends to continue its balanced approach of investing in growth and driving long-term operating efficiencies.

Management Comments

• Aflac delivered very solid adjusted earnings for the quarter.
• Aflac Japan's premium persistency was 93.8% and sales increased 12.6% year-over-year.
• Aflac continues to focus on third sector products, including Miraito, while introducing policies to new and younger customers through Tsumitasu.
• Aflac U.S. premium persistency results were 79.3%, with a 1.8% increase in net earned premiums and a 3.5% increase in sales.
• Aflac is encouraged by the momentum in group business, especially group life and disability as well as network dental.
• Aflac continues to focus on more profitable growth through stronger underwriting discipline and improving the productivity of agents and brokers.
• Aflac continues to generate strong capital and cash flows while maintaining a commitment to prudent liquidity and capital management.
• Aflac treasures its 2024 milestone of 42 consecutive years of dividend increases and remains committed to extending this record, supported by its financial strength.

Industry Context

Aflac's focus on supplemental health insurance products aligns with the increasing demand for financial protection against unexpected health expenses, particularly in the U.S. and Japan.

Comparison to Industry Standards

• Aflac's persistency rates in Japan (93.8%) are strong compared to industry averages, reflecting customer loyalty.
• Aflac's adjusted ROE of 12.7% and 15.6% excluding foreign currency remeasurement indicates efficient capital management.
• Companies like MetLife and Prudential Financial also operate in the insurance sector, but Aflac's focus on supplemental health insurance differentiates it.
• Aflac's dividend record of 42 consecutive years of increases is a benchmark for dividend-paying companies.

Stakeholder Impact

• Shareholders will receive a second quarter dividend of $0.58 per share.
• Policyholders will continue to receive financial protection through Aflac's insurance products.
• Employees will be impacted by the company's focus on expense management and efficiency.
• The company's strong capital position ensures its ability to meet its obligations to policyholders and creditors.

Next Steps

• Aflac will continue to focus on third sector products in Japan.
• Aflac will continue to focus on more profitable growth through stronger underwriting discipline and improving the productivity of agents and brokers in the U.S.
• Aflac will continue its balanced approach of investing in growth and driving long-term operating efficiencies.
• Aflac will continue to be flexible and tactical in how it manages the balance sheet and deploys capital.

Key Dates

Keywords

Aflac, earnings, financial results, Japan, U.S., premiums, investment income, dividends, share repurchase, insurance